Abstract：In countries and regions with high vaccination coverage, several vaccine-preventable diseases have been resurged in recent years, such as measles, varicella, pertussis and mumps. Some studies have found that the clinical manifestation and epidemiological characteristics of these diseases were different from those in pre-vaccine era. This article reviewed the clinical and epidemiological features of vaccine-preventable diseases before and after wide immunization implementation, focusing on the situation in China, in order to attract the attention of clinicians, raise awareness, strengthen prevention and control, and promote in-depth research for these diseases.
Sheridan SL, Frith K, Snelling TL, et al. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine:recent epidemiology[J]. Expert Rev Vaccines, 2014, 13(9):1081-1106.
[4]
Hewlett EL, Edwards KM. Clinical practice. Pertussis-not just for kids[J]. N Engl J Med, 2005, 352(12):1215-1222.
[5]
Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies[J]. Clin Microbiol Rev, 2005, 18(2):326-382.
[6]
Cherry JD. Pertussis in young infants throughout the world[J]. Clin Infect Dis, 2016, 63(suppl 4):S119-S122.
[7]
Yaari E, Yafe-Zimerman Y, Schwartz SB, et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults[J]. Chest, 1999, 115(5):1254-1258.
[8]
Wallace MR, Bowler WA, Oldfield EC 3rd. Treatment of varicella in the immunocompetent adult[J]. J Med Virol, 1993, Suppl 1:90-92.
[9]
Moore ZS, Seward JF, Watson BM, et al. Chickenpox or smallpox:the use of the febrile prodrome as a distinguishing characteristic[J]. Clin Infect Dis, 2004, 39(12):1810-1817.
[10]
Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated persons:clinical and epidemiological characteristics, 1997-2005[J]. J Infect Dis, 2008, 197 Suppl 2:S127-S131.
[11]
Seward JF, Zhang JX, Maupin TJ, et al. Contagiousness of varicella in vaccinated cases:a household contact study[J]. JAMA, 2004, 292(6):704-708.
[12]
Willocks LJ, Guerendiain D, Austin HI, et al. An outbreak of mumps with genetic strain variation in a highly vaccinated student population in Scotland[J]. Epidemiol Infect, 2017, 145(15):3219-3225.
[13]
Ma R, Lu L, Zhou T, et al. Mumps disease in Beijing in the era of two-dose vaccination policy, 2005-2016[J]. Vaccine, 2018, 36(19):2589-2595.
[14]
Vygen S, Fischer A, Meurice L, et al. Waning immunity against mumps in vaccinated young adults, France 2013[J]. Euro Surveill, 2016, 21(10):30156.
[15]
Chen CC, Lu CC, Su BH, et al. Epidemiologic features of mumps in Taiwan from 2006 to 2011:a new challenge for public health policy[J]. World J Pediatr, 2015, 11(2):141-147.
Ma R, Lu L, Zhangzhu J, et al. A measles outbreak in a middle school with high vaccination coverage and evidence of prior immunity among cases, Beijing, P.R. China[J]. Vaccine, 2016, 34(15):1853-1860.
[20]
Cui A, Mao N, Wang H, et al. Importance of real-time RTPCR to supplement the laboratory diagnosis in the measles elimination program in China[J]. PLoS One, 2018, 13(11):e0208161.
[21]
Orenstein WA, Markowitz LE, Atkinson WL, et al. Worldwide measles prevention[J]. Isr J Med Sci, 1994, 30(5-6):469-481.
[22]
Toizumi M, Vo HM, Dang DA, et al. Clinical manifestations of congenital rubella syndrome:a review of our experience in Vietnam[J]. Vaccine, 2019, 37(1):202-209.
[23]
Meng Q, Luo J, Li L, et al. Rubella seroprevalence among pregnant women in Beijing, China[J]. BMC Infect Dis, 2018, 18(1):130.
Wang C, Zhu Z, Xu Q, et al. Progress towards rubella elimination after implementation of rubella immunization for over 20 years in Shandong province, China[J]. Sci Rep, 2017, 7(1):17982.
